MEHMET KIVRAK | Biology and Life Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

MEHMET KIVRAK
Affiliation Recep Tayyip Erdogan University
Country Turkey
Scopus ID 57211715569
Documents 22
Citations 92
h-index 4
Subject Area Biology and Life Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-2405-8552

MEHMET KIVRAK

Recep Tayyip Erdogan University, Turkey

MEHMET KIVRAK is a researcher affiliated with Recep Tayyip Erdogan University whose scholarly work focuses on Biology and Life Sciences with interdisciplinary applications in clinical medicine, women’s health, artificial intelligence-assisted healthcare, and biomarker discovery. His research portfolio demonstrates consistent contributions to observational clinical studies and translational biomedical investigations published in peer-reviewed international journals.[1]

Abstract

This article summarizes the academic profile of MEHMET KIVRAK in relation to the Innovative Research Award. His published work spans clinical medicine, reproductive health, inflammatory biomarkers, cardiovascular risk assessment, and explainable artificial intelligence. The available publication record indicates sustained engagement in evidence-based biomedical research and collaboration across multiple clinical specialties, contributing to improved understanding of disease mechanisms and patient care.[2]

Keywords

Biology and Life Sciences; Clinical Medicine; Biomarkers; Artificial Intelligence; Women’s Health; Cardiovascular Risk; Medical Research.

Introduction

Modern biomedical research increasingly combines clinical observations with computational analysis to improve diagnosis and treatment. MEHMET KIVRAK has participated in investigations involving pregnancy-related disorders, polycystic ovary syndrome, dermatological diseases, and neurodevelopmental conditions. These studies illustrate an interdisciplinary approach integrating laboratory findings with clinical outcomes.[3]

Research Profile

According to the available author metrics, the researcher has produced 22 indexed documents receiving 92 citations with an h-index of 4. The research emphasizes prospective observational studies, biomarker evaluation, clinical epidemiology, and the application of explainable artificial intelligence to healthcare datasets. These activities reflect continued participation in internationally indexed scientific publishing.[1]

Research Contributions

  • Clinical investigations of hypertensive disorders during pregnancy and urinary health.
  • Evaluation of inflammatory biomarkers including IL-39 in polycystic ovary syndrome.
  • Explainable artificial intelligence for cardiovascular risk prediction in psoriasis.
  • Clinical follow-up studies examining ADHD treatment outcomes and emotional regulation.

Publications

  • Lower Urinary Tract System Symptoms and Urinary Incontinence in Hypertensive Disorders of Pregnancy (2026).
  • Evaluation of Serum IL-39 Levels in Patients with Polycystic Ovary Syndrome (2026).
  • Unveiling Key Biomarkers of Cardiovascular Risk in Psoriasis Through Explainable Artificial Intelligence (2026).
  • Associations with Methylphenidate Treatment in Emotion Regulation and Skin-Picking Severity in Adolescents with ADHD (2026).
  • Rize Bölgesindeki Gebelerde Emesis Gravidarum Prevalansı (2025).

Research Impact

The publication record demonstrates continuing contributions to clinical medicine and life sciences through peer-reviewed journals. Research outputs support understanding of women’s health, inflammatory mechanisms, predictive analytics, and evidence-based patient management. Citation activity indicates scholarly visibility and growing engagement within the international biomedical research community.[4]

Award Suitability

The research profile aligns with the objectives of the Global Innovation Technologist Awards by demonstrating interdisciplinary scientific investigation, peer-reviewed publication activity, and contributions to translational biomedical research. The combination of clinical expertise and emerging analytical methodologies represents a suitable basis for academic recognition within innovation-focused award programs.[5]

Conclusion

MEHMET KIVRAK’s scholarly activities reflect an emphasis on clinically relevant biomedical research supported by peer-reviewed publications and measurable research metrics. The available evidence highlights sustained contributions to Biology and Life Sciences while promoting interdisciplinary approaches that integrate clinical investigation with innovative analytical techniques.

References

  1. Elsevier. Scopus Author Details: MEHMET KIVRAK, Author ID 57211715569.
    https://www.scopus.com/pages/authors/57211715569
  2. Journal of Clinical Medicine. Lower Urinary Tract System Symptoms and Urinary Incontinence in Hypertensive Disorders of Pregnancy.
    https://doi.org/10.3390/jcm15114162
  3. Journal of Clinical Medicine. Evaluation of Serum IL-39 Levels in Patients with Polycystic Ovary Syndrome.
    https://doi.org/10.3390/jcm15103958
  4. Biology. Unveiling Key Biomarkers of Cardiovascular Risk in Psoriasis Through Explainable Artificial Intelligence.
    https://doi.org/10.3390/biology15070532
  5. Journal of Clinical Medicine. Associations with Methylphenidate Treatment in Emotion Regulation and Skin-Picking Severity in Adolescents with ADHD.
    https://doi.org/10.3390/jcm15062401
  6. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi. Rize Bölgesindeki Gebelerde Emesis Gravidarum Prevalansı.
    https://doi.org/10.17517/ksutfd.1621762